Net Cash Provided by (Used in) Financing Activities in USD of Cytosorbents Corp from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cytosorbents Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Cytosorbents Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $6.83M.
  • Cytosorbents Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $9.33M, a 35.5% decline from 2023.
  • Cytosorbents Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $14.5M, a 192% increase from 2022.
  • Cytosorbents Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.96M, a 593% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Cytosorbents Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $6.83M +$7.4M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q1 2024 -$572K -$1.26M -184% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q1 2023 $684K +$725K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$40.4K -$117K -153% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q1 2021 $76.6K -$17.8M -99.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q1 2020 $17.9M +$15.9M +792% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $2M -$4.44M -68.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q1 2018 $6.44M +$6.27M +3554% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 $176K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2015 $10M +$209K +2.13% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q1 2014 $9.8M +$9.35M +2078% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $450K -$1.25M -73.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q1 2012 $1.7M -$269K -13.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $1.97M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15

Cytosorbents Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $9.33M -$5.14M -35.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $14.5M +$9.51M +192% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $4.96M +$4.24M +593% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $715K -$65.6M -98.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $66.3M +$58.2M +711% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $8.18M -$9.29M -53.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $17.5M -$2.66M -13.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 $20.1M +$15.1M +297% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 $5.06M -$6.58M -56.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $11.6M +$1.62M +16.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $10M +$5.81M +138% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-31
2013 $4.2M -$7.92K -0.19% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $4.21M +$199K +4.95% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 $4.01M +$1.91M +90.8% Jan 1, 2011 Dec 31, 2011 10-K 2013-04-03
2010 $2.1M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.